Universal Allergy Immunotherapy Market 2018 Research Report implements a comprehensive study on Market Research Future. The report aims to provide an overview of Global Allergy Immunotherapy Market with Top Merchants and worldwide Segmentation. Forecast till 2023.
Allergy Immunotherapy Market Scenario:
The market for allergy immunotherapy was around USD 2,100.0 million in 2016 and is expected to reach USD 4,324.7 million by 2023 which is a projected CAGR of 10.85%.
Get Exclusive Sample Copy of Allergy Immunotherapy Market spread across 88 Premium Pages, 10+ and Supported with Full TOC, is Available @ https://www.marketresearchfuture.com/sample_request/1517
The Global Allergy Immunotherapy Market has been evaluated as a rapidly growing market and it is expected to continue growing in the near future. Allergy immunotherapy is a disease-adapting therapy, effective for the treatment allergic rhinitis/conjunctivitis, allergic asthma, peanuts allergy, cat allergy, and stinging insect hypersensitivity. According to the World Allergy Organization (WAO), approximately 10%-40% of the global population is suffering from allergy in 2013.
The Allergy Immunotherapy market is expected to grow at a steady pace. The factors influencing the growth of the market include increasing prevalence of gastrointestinal diseases, increasing prevalence of cancer, increasing investments and funding in the field of life science research, increasing awareness among the people, growing geriatric population, changing reimbursement policies and various others. Furthermore, factors such as presence of misbranded and spurious drugs is hampering the growth of the market.
Increasing demand for advance allergy treatment, increasing research and development activity, increasing research in improving the allergy treatment and introduction of new immunotherapeutic drugs are the major driving forces for the global allergy immunotherapy market. The demand for allergy immunotherapy treatment in emerging markets of Asia and Latin America is continuously growing that is another major factor for the market growth. Increasing knowledge of the immunotherapy, new product launches, increasing funding for R&D, and approvals are leading the market growth.
Some of the key players in this market are: ALK Abello A/S (Denmark), Allergy Therapeutics (UK), Circassia (UK), DBV Technologies (France), Stallergenes Greer (UK), Merck KGaA (Allergopharma) (Germany), HAL Allergy Group (Netherlands), and others.
Considering the global scenario of the allergy immunotherapy market, there are four main regions, the Americas, Europe, Asia Pacific, and Middle East & Africa.
Europe is holding the largest market share in global Allergy Immunotherapy Market. Some major factors that attribute the growth of Europe allergy immunotherapy market are, rise in prevalence of chronic diseases like allergy, asthma, diabetes and hypertension. Europe consists of two regions namely Western Europe and Eastern Europe. Western Europe is generating more revenue as compared to Eastern Europe.
The Americas are the second largest market share. The Americas mainly include North America and Latin America. Some key factors that are driving the growth for the American Allergy Immunotherapy market growth are increasing prevalence of allergic asthma, food allergy, and eczema, advanced healthcare facilities, and funding for research and new product or therapy development.
Global Allergy Immunotherapy market has been segmented on the basis of allergy type which comprise of allergic rhinitis, allergic asthma, peanut allergy, cat allergy, and other allergies.
On the basis of treatment, it is segmented into Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, and Specific Immunotherapy (SIT). Sublingual Immunotherapy is further sub-segmented into sublingual immunotherapy drops, and sublingual immunotherapy tablets.
- Allergic Rhinitis segment accounts for the largest market share in the global Allergy Immunotherapy market while peanut allergy segment is projected to grow at a CAGR of 11.30% during the forecast period from 2017 – 2023.
- Subcutaneous Immunotherapy (SCIT) segment accounts for the largest market share in the global Allergy Immunotherapy market by treatment, this segment is expected to reach US$ 2,089.2 in 2023
- Americas market is expected to reach US$ 1,409.6 by 2023
Major TOC of Global Allergy Immunotherapy Market Research Report Forecast to 2023:
1 REPORT PROLOGUE
2 MARKET INTRODUCTION$
3 RESEARCH METHODOLOGY$
4 MARKET DYNAMICS
5 MARKET FACTOR ANALYSIS
6 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY ALLERGY TYPE
7 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TREATMENT
8 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY REGION
9 COMPANY SHARE ANALYSIS
10 COMPANY PROFILE
Avail Stunning Discount @ https://www.marketresearchfuture.com/check-discount/1517
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312